After Johnson & Johnson’s vaccine, 6 cases of blood clot have been reported. These symptoms started appearing within 6 to 13 days of vaccination.
Cases of side effects of AstraZeneca and Johnson & Johnson vaccine are coming up. AFP
Corona cases are increasing rapidly in the world. Meanwhile, the quality of the COVID-19 vaccine (Corona Vaccine) is also constantly being questioned. Previously, people had been diagnosed with blood clots and death due to AstraZeneca vaccine. Now similar complaints have started coming from Johnson & Johnson company vaccine. Because of this, America has temporarily banned the use of this vaccine, while Australia has refused to buy it.
Even the Johnson & Johnson Company itself has stopped shipments sent to Europe. Recently, the European Agency for Medicine found the relationship between AstraZeneca’s vaccine and a rare blood clot in people. In Britain too, people under 30 years of age were advised to get another vaccine. Let’s know all the updates about these vaccines so far
What happened
There were reports about AstraZeneca and Johnson & Johnson’s vaccine that a rare type of blood clot has been reported since its introduction. The name of this blood clot is venous sinus thrombosis (CVST), which is caused by the lack of blood pellets in the body. The US Center for Disease Control and Prevention (CDC) committee reviewed Johnson & Johnson’s vaccine and blood clot cases, and the FDA will soon review it. According to the European Medicines Agency (EMA), as of April 4, 169 cases have been reported. Most cases have occurred within two weeks of taking the first dose of the vaccine.
Who are the side effects of the vaccine
After Johnson & Johnson’s vaccine, 6 cases of blood clot have been reported. All of them are women from 18 years to 48 years and these symptoms started appearing within 6 to 13 days of vaccination. However, till April 12, this vaccine has been given to 68 lakh people in the US. After taking AstraZeneca vaccine in Europe also, these cases were seen in women below 60 years.
What does the company say
Johnson & Johnson says it is working closely with the agency. He has not yet found any direct connection between the vaccine and the blood clot. AstraZeneca says that she is studying the cases exposed so far to find out the reason behind it.
What steps did the countries take regarding the vaccine
Johnson & Johnson’s single dose vaccine has been temporarily banned by the US CDC. The UK Medicines and Healthcare Products Regulatory Agency recommends that people under 30 years of age get a second vaccine instead of AstraZeneca. There is also a concern that the treatment of this rare blood clot is different. Commonly, a drug called heparin heparin is given in such cases, but in such cases it can be dangerous to do so.
read this also
Johnson & Johnson Vaccine: Johnson & Johnson postpone plans to bring vaccine to Europe after US ban
.